An interview with Jacob Morris, Software Engineering Supervisor – Infrastructure, Indica Labs
An interview with Jacob Morris, Software Engineering Supervisor – Infrastructure, Indica Labs
News
Multiplex Immunohistochemical Phenotyping of T cells in Primary Prostate Cancer
20 October 2022 | Join us for this 1-hour webinar to learn about an iterative chromogenic based Serial Stain workflow in HALO®
Multiplex Immunohistochemical Phenotyping of T cells in Primary Prostate Cancer Read More »
Press Release: Leica Biosystems Announces Partnership with Indica Labs to Deliver Integrated Digital Pathology Workflow Solutions for Mutual Customers
Vista, CA – Sep 4, 2022, Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Indica Labs, the industry-leading provider of computational and image management software in digital pathology, today announced a partnership focused on delivering compatible digital pathology workflow solutions.
Press Release: Indica Labs Announces Collaboration with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) for the Development of an AI-based Algorithm for the Automated Reporting of Lymph Node Status in Colon Cancer
Albuquerque, NM, and Glasgow, Scotland, – 30 August, 2022 – Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD), announced today an agreement to collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases.
HALO Prostate AI – A Tool for Automated Detection and Gleason Grading of Prostate Cancer
05 October 2022 | Join us for this 1-hour webinar to learn how to implement the HALO Prostate AI tool for prostate cancer detection and grading
HALO Prostate AI – A Tool for Automated Detection and Gleason Grading of Prostate Cancer Read More »
Quantitative Digital Pathology: An Overview of the HALO® Image Analysis Platform
6 October 2022 | Join us for this 1-hour webinar to see a live demonstration of the HALO® image analysis platform, the gold standard analysis platform for quantitative tissue analysis in digital pathology.
Quantitative Digital Pathology: An Overview of the HALO® Image Analysis Platform Read More »
Using Spatial Biology & Advanced Image Analysis Solutions to Decipher Tumor Microenvironment and the Drivers of Cancer Progression by Mass Spectrometry Imaging (MSI) and Imaging Mass Cytometry (IMC)
22 September 2022 | Join us for this 1-hour webinar and learn how MSI and IMC are advancing spatial biology through integration with other imaging and omic analyses
Panel discussion: Clustering analysis of highly multiplexed immunofluorescence assays analyzed with the HALO® image analysis platform
13 September 2022 | Join us for this 1.5-hour panel discussion on high dimensional clustering to learn about options for performing clustering analysis and for visualizing high dimensional HALO® Highplex FL data, such as UMAP and t-SNE.
Press Release: Deep Bio successfully integrates DeepDx® Prostate algorithm into HALO AP® platform from Indica Labs
Seoul, South Korea, and Albuquerque, NM – August 9, 2022 – Deep Bio, a company concentrating on SaMD (Software as a Medical Device) for digital pathology, is offering clinically validated, AI-based DeepDx® algorithms, and Indica Labs, a leading provider of computational pathology software and services, are excited to announce the successful integration of the DeepDx® Prostate algorithm into the HALO AP® platform from Indica Labs.